Clark, Andrew J <br/><br/>
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Apr 2016 
 - 3850-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1603018113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacokinetics<br/>Biomarkers, Tumor--metabolism<br/>Camptothecin--administration & dosage<br/>Carbonic Anhydrase IX--metabolism<br/>Cell Line, Tumor<br/>Cyclodextrins--administration & dosage<br/>DNA Topoisomerases, Type I--metabolism<br/>Endoscopy<br/>Esophageal Neoplasms--pathology<br/>Humans<br/>Mice<br/>Nanoparticles--administration & dosage<br/>Stomach Neoplasms--pathology<br/>Xenograft Model Antitumor Assays